-
with quantitative assay development, data analysis, and experimental troubleshooting Is able to work carefully with infection-relevant models and maintain rigorous documentation Is self-motivated
-
research • Deep learning and predictive modeling • Natural language processing and large language models for biomedical data • Drug response prediction and treatment optimization • Biomedical knowledge
-
innovation behaviors and processes and cultivate innovation ecosystems in complex organizations tackling multi-stakeholder, multi-attribute challenges. -Contribute to the Institute for Innovation Science's
-
, therapeutic development, and commercialization. The ideal candidate will possess extensive experience in molecular biology and in vivo cancer models and have a strong interest in RNA therapeutics and nucleic
-
microenvironment, and other biological processes. Conduct preclinical studies using in vivo disease models (cancer, inflammation, organ injury, etc.) and new alternative methodologies (advanced biological models
-
behavior of pests, their response to pesticides, including physiological and genetic mechanisms of resistance, innovations in applied pest management research (e.g., molecular, computational modeling
-
central component of this work is the development and application of machine-learning and AI techniques to identify weak, rare, or previously unknown nuclear transitions in complex spectral data. Advanced